Brookelynn K. Kendrick, NPC

Brookelynn Kendrick practices at Brevard Skin & Cancer Centers in Rockledge, Florida.

Brookelynn Kendrick's NPI, 1225412901, was assigned on July 13, 2015. Brookelynn Kendrick holds Florida license ARNP9314285.

Brookelynn Kendrick's primary practice is Brevard Skin & Cancer Centers, at 1286 Florida Ave, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 636-7780.

Brookelynn Kendrick's primary practice is Brevard Skin & Cancer Centers in Rockledge, Florida. The medical group on file is Brevard Skin and Cancer Center. Dmand AI also links Brookelynn Kendrick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Brookelynn Kendrick practices. Vendor and product names are available with a free account.

Nurse practitioner is Brookelynn Kendrick's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Brookelynn Kendrick is licensed in Florida.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, itchy rashes and skin cyst among the conditions Brookelynn Kendrick treats.

CMS data shows 4,209 Medicare services from Brookelynn Kendrick across 18 procedure codes in 2024, for 956 Medicare patients. Medicare paid $165,971 for them. Every service was in an office.

CMS counts 956 Medicare patients who saw Brookelynn Kendrick in 2024. The largest group is 65 to 74, with 471 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Brookelynn Kendrick's median patient age at 70, with 62% women.

In 2024, Brookelynn Kendrick wrote 908 Medicare Part D claims for 362 patients. 90% of them were for generic drugs. CMS names the drug for 753 of them, across 21 drugs with 11 or more claims each, at $580,312 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Brookelynn Kendrick for performance year 2024, reported individually. Brookelynn Kendrick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 103 general payments to Brookelynn Kendrick from 16 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 91% of the total. Janssen Pharmaceuticals, Inc paid the most, $917.